Luminex Corporation (NASDAQ:LMNX), a developer of biological testing technologies, reported fourth-quarter fiscal 2011 adjusted earnings of 11 cents a share, outpacing both the Zacks Consensus Estimate and the year-ago earnings of 7 cents a share. The adjusted earnings exclude costs associated with the company’s acquisition of EraGen Biosciences.
Profit rose 7.6% year over year to $3.4 million (or 8 cents a share) as the Texas-based company saw double-digit growth in its top line, backed by a … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards